Alexander Krushelnitsky's failed drug test shook the Pyeongchang Olympics on Monday, a week after he won bronze with his wife, Anastasia Bryzgalova.
Now Norway's Magnus Nedregotten has called on organisers and the Court of Arbitration for Sport (CAS) to expedite the process so he and partner Kristin Sasklien can learn if they have been promoted to third.
"Knowing that we may have been robbed and having to wait to see what happens is obviously emotional, and very stressful," said Nedregotten, whose medal hopes were dashed after an 8-4 defeat by the Olympic Athletes from Russia (OAR) pair.
"But (if guilty), the preferred option would be to receive the bronze medal at some point during the remainder of the Olympics. Receiving the medals this week would definitely be better than in a year's time."
Nedregotten revealed his subsequent shock at learning that Krushelnitsky had tested positive for a banned substance.
"At first the main feelings were anger," he said. "Weve been struggling through the Olympics, trying hard to reach our goal, which was a medal.
"If (Krushelnitsky is found guilty) then they've robbed us of our moment of glory, receiving our medal in the stadium. That's not cool, that's hard to accept, feeling that youve been kept out of the light."
A source told AFP he had taken the banned drug meldonium -- the same substance that earned Russian tennis star Maria Sharapova a suspension.
It is designed to treat heart problems and diabetes and can increase endurance and recovery.
But many observers and even Olympic curlers themselves were stunned and asked what role performance-enhancing drugs could possibly have in the slow-moving sport.
Nedregotten, however, thinks otherwise.
"It could have benefited those guys (OAR) as they had a really late game when they lost their semi-final," he said.
"Then they were playing early the next morning against us in the bronze match.
"I know in my case I would have liked to be more fresh in some of those games and have more energy, at least mentally.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
